BioLegend purchases Covance’s antibody products, manufacturing business
Antibody and reagent developer and manufacturer BioLegend on Tuesday acquired Covance’s antibody services unit for an undisclosed sum.
Archives for September 2, 2014
Layoffs possible as Ricerca Biosciences in discussions to be acquired, CEO says
Ohio-based CRO (contract research organization) Ricerca Biosciences is holding “ongoing discussions with several parties” about the possible sale of one or more of its divisions or the entire company, CEO Tim Derrington told us.
‘James bond’-like tech is the end to overdoses, says formulation firm
Canadian drugmaker Intellipharmaceutics has developed a kill-switch formulation it says will prevent drug misuse and accidental overdoses.
Roche cuts 100 Spanish jobs in downsizing drive
Roche has revealed plans to cut 100 jobs from its business in Spain “due to restructuring efforts to improve business efficiency.”
TransCelerate recommends what to protect in trial transparency efforts
Industry group TransCelerate Biopharma has developed a new recommended approach for protecting patients’ personal data in Clinical Study Reports (CSRs) shared with researchers, patients and others as part of plans to release more data under consideration...
West eyes up Waterford, Ireland facility in expanding network
West Pharmaceutical Services has confirmed it is evaluating potential expansions but says rumours that it plans to pay €100m ($130m) for a facility in Ireland are premature.
400 R&D jobs cut as Novo Nordisk says goodbye to inflammatory work
Novo Nordisk has scrapped all its inflammatory disease therapy development programmes, cutting 400 jobs.
Update
Former Cetero researcher rebukes US FDA over warning letter
A former researcher of the now dissolved CRO Cetero Research told us the warning letter he received from US FDA was “contrived” because of the way the inspection was conducted.